| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From INSERM U541, Hôpital Lariboisière, and IFR Circulation-Paris 7, Université Paris 7-Denis Diderot (S.B., J.-S.S., M.D., B.I.L., A.T.), France; and CNRS et Université Pierre et Marie Curie (J.B., Y.L.-D., J.M.), FRE 2371 Neurobiologie des Processus Adaptatifs, Laboratoire DVSN, Paris, France.
Correspondance to Alain Tedgui, U541-INSERM, 41 Bd de la Chapelle, 75475 Paris cedex 10, France. E-mail tedgui{at}infobiogen.fr
Ror
is an orphan nuclear receptor. In homozygous staggerer mutant mice (Rorasg/sg), a deletion within the Rora gene leads to an overexpression of inflammatory cytokines. Because inflammation and hypoxia are 2 key stimuli of ischemia-induced angiogenesis, we studied the role of Ror
in this setting. Ischemia was induced by ligation of the right femoral artery in C57BL/6 Rora+/+ and Rorasg/sg mice. After 3 and 28 days, angiogenesis was evaluated by microangiography, measurement of capillary density using immunohistochemistry (anti-CD31), and measurement of blood flow by laser Doppler imaging. At day 3, angiographic score and blood flow were similar in Rorasg/sg mice and in Rora+/+ littermates. Conversely, at day 28, Rorasg/sg mice showed a significant 2-fold increase in angiographic score and a 3-fold increase in capillary density within the ischemic hindlimb compared with control. Functionally, this coincided with a significant rise in leg perfusion in Rorasg/sg mice (0.83±0.05 for ischemic/nonischemic leg perfusion ratio) compared with Ror+/+ mice (0.66±0.04, P<0.05). In addition, more extensive angiogenesis in Rorasg/sg mice correlated with an increased expression of eNOS protein by 83±12% and 71±24% at 3 and 28 days, respectively (P<0.05), whereas the level of the antiangiogenic cytokine IL-12 was significantly reduced by 38±10% at day 28 (P<0.05). Conversely, no changes in VEGF expression were observed. Our study identifies for the first time a new role for Ror
as a potent negative regulator of ischemia-induced angiogenesis.
Key Words: Ror
nuclear receptors angiogenesis ischemia inflammation
This article has been cited by other articles:
![]() |
T. Wada, H. S. Kang, A. M. Jetten, and W. Xie The Emerging Role of Nuclear Receptor ROR{alpha} and Its Crosstalk with LXR in Xeno- and Endobiotic Gene Regulation Experimental Biology and Medicine, October 1, 2008; 233(10): 1191 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-J. Kim, Y.-G. Yoo, W.-K. Yang, Y.-S. Lim, T.-Y. Na, I.-K. Lee, and M.-O. Lee Transcriptional Activation of HIF-1 by ROR{alpha} and its Role in Hypoxia Signaling Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1796 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Duez and B. Staels The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolism Diabetes and Vascular Disease Research, June 1, 2008; 5(2): 82 - 88. [Abstract] [PDF] |
||||
![]() |
V. van Weel, R.E.M. Toes, L. Seghers, M.M.L. Deckers, M.R. de Vries, P.H. Eilers, J. Sipkens, A. Schepers, D. Eefting, V.W.M. van Hinsbergh, et al. Natural Killer Cells and CD4+ T-Cells Modulate Collateral Artery Development Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2310 - 2318. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Migita and J. Morser 15-Deoxy-{Delta}12,14-Prostaglandin J2 (15d-PGJ2) Signals Through Retinoic Acid Receptor-Related Orphan Receptor-{alpha} but Not Peroxisome Proliferator-Activated Receptor-{gamma} in Human Vascular Endothelial Cells: The Effect of 15d-PGJ2 on Tumor Necrosis Factor-{alpha}-Induced Gene Expression Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 710 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Miki, M. Ikuta, and T. Matsui Hypoxia-induced Activation of the Retinoic Acid Receptor-related Orphan Receptor {alpha}4 Gene by an Interaction between Hypoxia-inducible Factor-1 and Sp1 J. Biol. Chem., April 9, 2004; 279(15): 15025 - 15031. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Boukhtouche, J. Mariani, and A. Tedgui The "CholesteROR" Protective Pathway in the Vascular System Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Raspe, G. Mautino, C. Duval, C. Fontaine, H. Duez, O. Barbier, D. Monte, J. Fruchart, J.-C. Fruchart, and B. Staels Transcriptional Regulation of Human Rev-erbalpha Gene Expression by the Orphan Nuclear Receptor Retinoic Acid-related Orphan Receptor alpha J. Biol. Chem., December 13, 2002; 277(51): 49275 - 49281. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Delerive, W. W. Chin, and C. S. Suen Identification of Reverbalpha as a Novel RORalpha Target Gene J. Biol. Chem., September 13, 2002; 277(38): 35013 - 35018. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |